Canine parvovirus (CPV) is a host range variant of a feline virus that acquired the ability to infect dogs through changes in its capsid protein. Canine and feline viruses both use the feline transferrin receptor (TfR) to infect feline cells, and here we show that CPV infects canine cells through its ability to specifically bind the canine TfR. Receptor binding on host cells at 37°C only partially correlated with the host ranges of the viruses, and an intermediate virus strain (CPV type 2) bound to higher levels on cells than did either the feline panleukopenia virus or a later strain of CPV. During the process of adaptation to dogs the later variant strain of CPV gained the ability to more efficiently use the canine TfR for infection and also showed reduced binding to feline and canine cells compared to CPV type 2. Differences on the top and the side of the threefold spike of the capsid surface controlled specific TfR binding and the efficiency of binding to feline and canine cells, and these differences also determined the cell infection properties of the viruses.Canine parvovirus (CPV) emerged in 1978 as the cause of new enteric and myocardial diseases in dogs. The new virus spread globally in a pandemic of disease during 1978 and has since remained endemic in dogs throughout the world (27, 43). The 1978 strain of CPV (termed CPV type 2) was a new virus infecting dogs since there is no serological or other evidence for infection of dogs by a related virus prior to the mid-1970s (27). Phylogenetic analysis shows that all CPV isolates were descended from a single ancestor which emerged during the mid-1970s, which was closely related to the long-known feline panleukopenia virus (FPV) which infects cats, mink, and raccoons but not dogs or cultured dog cells (43). FPV and CPV isolates differ by as little as 0.5% in DNA sequence, and the characteristic properties of CPV type 2 are controlled by a small number of changes in the capsid surface. Two differences between FPV and CPV changed VP2 residues 93 from Lys to Asn and 323 from Asp to Asn, and those changes alone could introduce the canine host range, a CPV-specific antigenic epitope, and a difference in the pH dependence of hemagglutination into FPV (9, 14). Despite the close relationship to FPV, CPV type 2 isolates did not replicate in cats (42,44), and this host range was determined at least in part by VP2 residues 80, 564, and 568 which are in close proximity in the capsid structure (41). Other mutations in the same structural region of CPV type 2 were selected by passage in cat cells (VP2 residue 300 from Ala to Asp), and these reduced the infection of canine cells, as did closely adjacent changes in in vitro prepared mutants (VP2 residue 299 Gly to Glu) (18,26).Host range-controlling residues are located on a raised region of the capsid that surrounds the threefold axis (the threefold spike) (9, 46). VP2 residues 93 and 323 are found near the top of that structure, whereas residues 299 and 300, and changes controlling feline host range, are all on a ridge ...